Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder

Neuromodulation

Volumn 19, Issue 3, 2016, Pages 299-305

  Cook, Ian A ^a,b,c,d   Abrams, Michelle ^a,b   Leuchter, Andrew F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Engineering IV   (United States)

^d NeuroSigma Inc   (United States)

Author keywords

external stimulation of the trigeminal nerve; major depressive disorder; neuromodulation; non invasive brain stimulation; posttraumatic stress disorder; trigeminal nerve stimulation

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; ELECTRODE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; NERVE STIMULATION; NERVE STIMULATOR; OPEN STUDY; PATIENT SAFETY; POSTTRAUMATIC STRESS DISORDER; PTSD PATIENT CHECKLIST; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; REMISSION; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESPONSE; TRIGEMINAL NERVE STIMULATION; ADOLESCENT; AGED; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; ELECTROTHERAPY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; TRIGEMINAL NERVE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; TRIGEMINAL NERVE; YOUNG ADULT;

EID: 84958225294     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12399     Document Type: Article

References (60)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
2. Sundin J, Fear NT, Iversen A, Rona RJ, Wessely S., PTSD after deployment to Iraq: conflicting rates, conflicting claims. Psychol Med 2010; 40: 367-382.
3. Kessler RC., Posttraumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 2000; 61: 4-14.
4. Rytwinski NK, Scur MD, Feeny NC, Youngstrom EA., The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress 2013; 26: 299-309.
5. Flory JD, Yehuda R., Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin Neurosci 2015; 17: 141-150.
6. Rothbaum BO, Cahill SP, Foa EB, et al., Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress 2006; 19: 625-638.
7. Sullivan GM, Neria Y., Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials. Curr Opin Investig Drugs 2009; 10: 35-45.
8. Ipser JC, Stein DJ., Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol 2012; 15: 825-840.
9. Bisson J, Andrew M., Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews 2007; CD003388. doi: 10.1002/14651858.CD003388.pub3.
10. Bradley R, Greene J, Russ E, Dutra L, Westen D., A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 2005; 162: 214-227.
11. Pratchett LC, Daly K, Bierer LM, Yehuda R., New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder. Expert Opin Pharmacother 2011; 12: 2339-2354.
12. Blanchard EB, Buckley TC, Hickling EJ, Taylor AE., Posttraumatic stress disorder and comorbid major depression: is the correlation an illusion? J Anxiety Disord 1998; 12: 21-37.
13. Raab PA, Mackintosh MA, Gros DF, Morland LA., Impact of comorbid depression on quality of life in male combat Veterans with posttraumatic stress disorder. J Rehabil Res Dev 2015; 52: 563-576.
14. Yehuda R., Biology of posttraumatic stress disorder. J Clin Psychiatry 2001; 62 Suppl. 17: 41-46.
15. Yehuda R, Flory JD, Southwick S, Charney DS., Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann N Y Acad Sci 2006; 1071: 379-396.
16. Langevin JP, De Salles AA, Kosoyan HP, Krahl SE., Deep brain stimulation of the amygdala alleviates post-traumatic stress disorder symptoms in a rat model. J Psychiatr Res 2010; 44: 1241-1245.
17. Stidd DA, Vogelsang K, Krahl SE, Langevin JP, Fellous JM., Amygdala deep brain stimulation is superior to paroxetine treatment in a rat model of posttraumatic stress disorder. Brain Stimul 2013; 6: 837-844.
18. Sui L, Huang S, Peng B, Ren J, Tian F, Wang Y., Deep brain stimulation of the amygdala alleviates fear conditioning-induced alterations in synaptic plasticity in the cortical-amygdala pathway and fear memory. J Neural Transm 2014; 121: 773-782.
19. Barkay G, Freedman N, Lester H, et al., Brain activation and heart rate during script-driven traumatic imagery in PTSD: preliminary findings. Psychiatry Res 2012; 204: 155-160.
20. Simmons AN, Norman SB, Spadoni AD, Strigo IA., Neurosubstrates of remission following prolonged exposure therapy in veterans with posttraumatic stress disorder. Psychother Psychosom 2013; 82: 382-389.
21. Roy MJ, Costanzo ME, Blair JR, Rizzo AA., Compelling evidence that exposure therapy for PTSD normalizes brain function. Stud Health Technol Inform 2014; 199: 61-65.
22. Thomaes K, Dorrepaal E, Draijer N, Jansma EP, Veltman DJ, van Balkom AJ., Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review. J Psychiatr Res 2014; 50: 1-15.
23. Lisanby SH, Belmaker RH., Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety 2000; 12: 178-187.
24. Leuchter AF, Cook IA, Jin Y, Phillips B., The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci 2013; 7: 37.
25. Slotema CW, Blom JD, Hoek HW, Sommer IE., Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010; 71: 873-884.
26. George MS, Padberg F, Schlaepfer TE, et al., Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimul 2009; 2: 14-21.
27. Novakovic V, Sher L, Lapidus KA, Mindes J, A Golier J, Yehuda R., Brain stimulation in posttraumatic stress disorder. Eur J Psychotraumatol 2011; 2: 5609. doi: 10.3402/ejpt.v2i0.5609.
28. Karsen EF, Watts BV, Holtzheimer PE., Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. Brain Stimul 2014; 7: 151-157.
29. DeGiorgio CM, Shewmon DA, Whitehurst T., Trigeminal nerve stimulation for epilepsy. Neurology 2003; 61: 421-422.
30. DeGiorgio CM, Shewmon A, Murray D, Whitehurst T., Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial. Epilepsia 2006; 47: 1213-1215.
31. DeGiorgio CM, Murray D, Markovic D, Whitehurst T., Trigeminal nerve stimulation for epilepsy: long-term feasibility and efficacy. Neurology 2009; 72: 936-938.
32. DeGiorgio CM, Soss J, Cook IA, et al., Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology 2013; 80: 786-791.
33. Schrader LM, Cook IA, Miller PR, Maremont ER, DeGiorgio CM., Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav 2011; 22: 475-478.
34. Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF., Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav 2013; 28: 221-226.
35. Shiozawa P, Duailibi MS, da Silva ME, Cordeiro Q., Trigeminal nerve stimulation (TNS) protocol for treating major depression: an open-label proof-of-concept trial. Epilepsy Behav 2014; 39: 6-9.
36. Shiozawa P, da Silva ME, Netto GT, Taiar I, Cordeiro Q., Effect of a 10-day trigeminal nerve stimulation (TNS) protocol for treating major depressive disorder: a phase II, sham-controlled, randomized clinical trial. Epilepsy Behav 2015; 44: 23-26.
37. McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA., An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Brain Stimul 2015; 8: 299-304.
38. Chae JH, Nahas Z, Lomarev M, et al., A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003; 37: 443-455.
39. Jean A., The nucleus tractus solitarius: neuroanatomic, neurochemical and functional aspects. Arch Int Physiol Biochim Biophys 1991; 99: A3-A52.
40. Henry TR., Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002; 59 (Suppl 4): S3-S14.
41. Norgren R., Projections from the nucleus of the solitary tract in the rat. Neuroscience 1978; 3: 207-218.
42. Ricardo JA, Koh ET., Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res 1978; 153: 1-26.
43. Ruffoli R, Giorgi FS, Pizzanelli C, Murri L, Paparelli A, Fornai F., The chemical neuroanatomy of vagus nerve stimulation. J Chem Neuroanat 2011; 42: 288-296.
44. Zerari-Mailly F, Buisseret P, Buisseret-Delmas C, Nosjean A., Trigemino-solitarii-facial pathway in rats. J Comp Neurol 2005; 487: 176-189.
45. Sheehan DV, Lecrubier Y, Sheehan KH, et al., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 22-33.
46. Hamilton M., A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
47. Blanchard EB, Hickling EJ, Taylor AE, Forneris CA, Loos W, Jaccard J., Effects of varying scoring rules of the Clinician-Administered PTSD Scale (CAPS) for the diagnosis of post-traumatic stress disorder in motor vehicle accident victims. Behav Res Ther 1995; 33: 471-475.
48. Weathers FW, Litz BT, Huska JA, Keane TM., PCL-C for DSM-IV. Boston: National Center for PTSD-Behavioral Science Division, 1994.
49. Rush AJ, Trivedi MH, Ibrahim HM, et al., The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583.
50. Endicott J, Nee J, Harrison W, Blumenthal R., Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29: 321-326.
51. Rabkin JG, Markowitz JS, Ocepek-Welikson K, Wager SS., General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol 1992; 12: 3-10.
52. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA, STARD Investigators. Self-rated global measure of frequency, intensity, and burden of side effects. J Psychiatry Practice 2006; 12: 71-79.
53. Mischoulon D, Price LH, Carpenter LL, et al., A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder. J Clin Psychiatry 2014; 75: 370-376.
54. DeWalt DA, Callahan LF, Hawk VH, et al., Health Literacy Universal Precautions Toolkit. (Prepared by North Carolina Network Consortium, The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, under Contract No. HHSA290200710014.) AHRQ Publication No. 10-0046-EF) Rockville, MD. Agency for Healthcare Research and Quality. April 2010.
55. Faul F, Erdfelder E, Lang AG, Buchner A., G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191.
56. Wadekar M, Sharma A, Battaglia G., Patient-Centered Outcomes Research (PCOR): How can we optimize outcomes in CNS research? Innov Clin Neurosci 2015; 12: 27-31.
57. Fanselow EE., Central mechanisms of cranial nerve stimulation for epilepsy. Surg Neurol Int 2012; 3 (Suppl 4): S247-S254.
58. Yuan H, Silberstein SD., Vagus nerve and vagus nerve stimulation, a comprehensive review: Part III. Headache 2015; e-pub ahead of print. doi: 10.1111/head.12649
59. Hinwood M, Morandini J, Day TA, Walker FR., Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 2012; 22: 1442-1454.
60. Bollinger JL, Bergeon Burns CM, Wellman CL., Differential effects of stress on microglial cell activation in male and female medial prefrontal cortex. Brain Behav Immun 2016; 52: 88-97.